obesity pharmacotherapy
Petrelintide: The Weight Loss Drug That Works Without the Nausea
A new amylin analogue (petrelintide) posted Phase 1 results: 8.6% body weight reduction at 16 weeks, nausea rate identical to placebo. Here's what that means for GLP-1 dropouts.